Jeremy Bellien
- PhD, HDR, PU-PH Pharmacology, Director of INSERM UMR1096
Researchgate Orcid (0000-0002-0383-2342)
PHASM : Phosphatase activity of the enzyme Soluble epoxide hydrolase as a new target in cardiometabolic diseases / L'activité phosphatase de l'époxyde hydrolase soluble comme nouvelle cible dans les maladies cardiométaboliques
SAPHIR : Impact of the modulation of Soluble epoxide hydrolase enzymatic Activities on Pulmonary HypertensIon and Right ventricular dysfunction in experimental and human heart failure